In a rapidly changing world, MADE in Germany examines the risks and benefits of digitalization and its impact on the way we work, what we earn and how we live.
New drugs constantly hit the market, increasing patients' odds of recovery. Someone with 40,000 euros can buy a cure for cirrhosis of the liver and hepatitis C. Are such prices justified? Should companies be allowed to make billions in profits?